Replies to post #252955 on Avid Bioservices Inc (CDMO)

[Protector]

north4K, you know that even if GILD is interested in Liver Cancer they will have to fight Sorafenib (Bayer-Onyx).

B-O have the advantage to already have PII data of Sorafenib + bavituximab and Yopp is consultant for Bayer and at UTSW running PPHM's Liver Cancer trial.

Running, not recruiting.
Primary completion date DEC 2015 so assuming they need 3 months to compile and process data and prepare FDA PII meeting we may hear from this the coming weeks/months. IMO PPHM will NOT start ANY Liver Cancer CT without a specific Liver Cancer Partner/Collaborator.

I am not saying that it is impossible but for GILD to get into Liver Cancer it will probably not be by getting hands on Bavi (that is not sufficiently Liver-Specific). They may have a Sorafenib competitor in sight and possibly think about a COMBO with Bavi and try to go for a new SOC. If they do that they become a direct competitor/challenger for B-O because we know that the COMBO's will change the landscape the coming decades.

Maybe GILD has some IO for Liver + Bavi in mind?

[Protector]

north, I see I replied to your question in my last reply to James.

See end of post..

I have been reading the article you provided on ICTP. ICTP searching to sell will be good for the PPS until a price is known. The fact that ICTP takes the initiative to sell itself doesn't sit good with me. They had already a bump in the road between initial result announcement and later correction (that costed them many dollars in the PPS - they once were about 500$).

I wonder if there may be a NEXT problem and they prefer to sell now.

...exploring a potential sale after receiving interest from other companies,
...
Intercept has been working with investment bankers to explore the prospect of a sale,...

They had interest from others that CLEARLY was insufficient or they would not go to an investment banker for more others. This points to a valuation discrepancy. ICTP wants more then interested parties want to give.

If you have the goods then that is no problem you just continue business. But if you may think that sooner or later something could surface that shows the goods are not as spectacular as expected then you may want to sell using the 'interest of others' as an attention attraction for still others.


If PPHM for instance would not take a certain offer that is one thing. If however they would upon that event go to an investment banker and put themselves in the show-room then I would be worried. There is a difference between you being in the show-room and yell BUY ME, BUY ME... and being contacted by others that want to talk to see if you would be in the market and/or if they would be allowed to make a free offer to see if you would then be in the market. AIMO.